secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evofem Biosciences, Inc. (EVFM)
CIK:        0001618835
Form:       8-K
Filed at:   2024-10-28T23:59:59+00:00
Accession:  0001493152-24-042605
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evofem raises $2.28M via private placement of Series F-1 Preferred Stock to Aditxt
--------------------------------------------------------------------------------

- Aditxt purchased 2,280 Series F-1 Preferred Stock shares for $2,280,000 in a private placement.
- Shares are convertible into common stock; company granted registration rights for resale.
- Private placement closed Oct 28, 2024; exempt from registration under Section 4(a)(2) of Securities Act.
- Part of consideration for A&R Merger Agreement with Aditxt, as previously disclosed.
- Company filed Registration Rights Agreement to register conversion shares within 300 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1618835/000149315224042605/0001493152-24-042605-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1618835/000149315224042605/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-042605

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer